Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


28.08.2017

1 AJR Am J Roentgenol
1 Am J Gastroenterol
1 Ann Intern Med
2 Anticancer Res
2 Biochem Biophys Res Commun
2 BMC Cancer
2 Cancer
3 Dig Dis Sci
1 Endoscopy
2 Gut
12 Hepatology
2 J Gastroenterol
1 J Gastroenterol Hepatol
2 J Hepatol
1 Lancet Infect Dis
1 PLoS Comput Biol
23 PLoS One
4 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. PAIGE JS, Bernstein GS, Heba E, Costa EA, et al
    A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2017 Mar 7:W1-W10. doi: 10.2214/AJR.16.16726.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. BUGIANESI E, Bizzarri C, Rosso C, Mosca A, et al
    Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2017;112:1277-1286.
    PubMed     Text format     Abstract available


    Ann Intern Med

  3. ZENNER D, Beer N, Harris RJ, Lipman MC, et al
    Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
    Ann Intern Med. 2017 Aug 1. doi: 10.7326/M17-0609.
    PubMed     Text format     Abstract available


    Anticancer Res

  4. SHIBA I, Kouzaki R, Yamada H, Endo Y, et al
    Design and Synthesis of Novel Anti-metastatic Hypoxic Cytotoxin TX-2137 Targeting AKT Kinase.
    Anticancer Res. 2017;37:3877-3883.
    PubMed     Text format     Abstract available

  5. ISHII F, Yoshida Y, Yamauchi Y, Aisu N, et al
    Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated alphabeta T-cells.
    Anticancer Res. 2017;37:3933-3939.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  6. XU JH, Chang WH, Fu HW, Shu WQ, et al
    Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC.
    Biochem Biophys Res Commun. 2017;490:920-926.
    PubMed     Text format     Abstract available

  7. YANG H, Xing R, Liu S, Yu H, et al
    Rescuing fluoride-induced damages in liver with gamma aminobutyric acid.
    Biochem Biophys Res Commun. 2017;491:19-24.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. ZHAO YJ, Zhou DC, Liu FB, Zhao HC, et al
    BiClamp(R) vessel-sealing device for open hepatic resection of malignant and benign liver tumours: a single-institution experience.
    BMC Cancer. 2017;17:554.
    PubMed     Text format     Abstract available

  9. CHEN D, Chen Y, Yan Y, Pan J, et al
    Down-regulation of the tumour suppressor kappa-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    BMC Cancer. 2017;17:553.
    PubMed     Text format     Abstract available


    Cancer

  10. KIM Y, Lee SJ, Lee JY, Lee SH, et al
    Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
    Cancer. 2017;123:1958-1964.
    PubMed     Text format     Abstract available

  11. TRAN CAO HS, Zhang Q, Sada YH, Chai C, et al
    The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30968.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  12. WU S, Yang C, Xu N, Wang L, et al
    The Protective Effects of Helix B Surface Peptide on Experimental Acute Liver Injury Induced by Carbon Tetrachloride.
    Dig Dis Sci. 2017;62:1537-1549.
    PubMed     Text format     Abstract available

  13. CHEDID MF
    Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.
    Dig Dis Sci. 2017 Aug 24. doi: 10.1007/s10620-017-4724.
    PubMed     Text format    

  14. CHENG L, Wang H, Han S
    MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 19. doi: 10.1007/s10620-017-4670.
    PubMed     Text format     Abstract available


    Endoscopy

  15. KONDO H, Naitoh I, Nakazawa T, Hayashi K, et al
    Development of fatal systemic gas embolism during direct peroral cholangioscopy under carbon dioxide insufflation.
    Endoscopy. 2016;48.
    PubMed     Text format    


    Gut

  16. GRIESMANN H, Drexel C, Milosevic N, Sipos B, et al
    Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
    Gut. 2016 Mar 24. pii: gutjnl-2015-310049. doi: 10.1136/gutjnl-2015-310049.
    PubMed     Text format     Abstract available

  17. HARDY T, Zeybel M, Day CP, Dipper C, et al
    Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
    Gut. 2017;66:1321-1328.
    PubMed     Text format     Abstract available


    Hepatology

  18. DEMAREZ C, Gerard C, Cordi S, Poncy A, et al
    MiR-337-3p controls hepatobiliary gene expression and transcriptional dynamics during hepatic cell differentiation.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29475.
    PubMed     Text format     Abstract available

  19. PARIKH ND, Marrero WJ, Wang J, Steuer J, et al
    Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29473.
    PubMed     Text format     Abstract available

  20. FRIEDMAN SL, Ratziu V, Harrison SA, Abdelmalek MF, et al
    A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29477.
    PubMed     Text format     Abstract available

  21. WARD ES, Ober RJ
    Hepatic function of FcRn revealed: Implications for overcoming drug-mediated hepatotoxicity.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29476.
    PubMed     Text format    

  22. RIAZ A, Gabr A, Abouchaleh N, Ali R, et al
    Radioembolization for Hepatocellular Carcinoma: Statistical Confirmation of Improved Survival in Responders by Landmark Analyses.
    Hepatology. 2017 Aug 18. doi: 10.1002/hep.29480.
    PubMed     Text format     Abstract available

  23. YANG JD, Malhi H
    Green Tea Consumption - A Potential Chemopreventive Measure for Hepatocellular Carcinoma?
    Hepatology. 2017 Aug 21. doi: 10.1002/hep.29481.
    PubMed     Text format    

  24. KABIR TD, Ganda C, Brown RM, Beveridge DJ, et al
    A miR-7/GAS6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
    Hepatology. 2017 Aug 18. doi: 10.1002/hep.29478.
    PubMed     Text format     Abstract available

  25. VYAS D, Baptista PM, Brovold M, Moran E, et al
    Self-assembled liver organoids recapitulate hepato-biliary organogenesis in vitro.
    Hepatology. 2017 Aug 23. doi: 10.1002/hep.29483.
    PubMed     Text format     Abstract available

  26. SCHWARTZ RE, Batisti J, Brown RS Jr, Tafesh Z, et al
    Hepatology Highlights.
    Hepatology. 2017;66:683-685.
    PubMed     Text format    

  27. DEL CHIERICO F, Nobili V, Vernocchi P, Russo A, et al
    Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
    Hepatology. 2017;65:451-464.
    PubMed     Text format     Abstract available

  28. FENG S, Demetris AJ, Spain KM, Kanaparthi S, et al
    Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28681.
    PubMed     Text format     Abstract available

  29. SPENGLER EK, Kleiner DE, Fontana RJ
    Vemurafenib-induced Granulomatous hepatitis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28692.
    PubMed     Text format    


    J Gastroenterol

  30. KOBAYASHI K, Maruyama H, Kiyono S, Ogasawara S, et al
    Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis.
    J Gastroenterol. 2017 Aug 18. doi: 10.1007/s00535-017-1378.
    PubMed     Text format     Abstract available

  31. IMPERATORE N, Tortora R, Anna T, Gerbino N, et al
    Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.
    J Gastroenterol. 2017 Aug 19. doi: 10.1007/s00535-017-1381.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  32. CHIRAPONGSATHORN S, Bunraksa W, Chaiprasert A, Punpanich D, et al
    Adding C-reactive protein and procalcitonin to the MELD score improves mortality prediction in patients with complications of cirrhosis.
    J Gastroenterol Hepatol. 2017 Aug 25. doi: 10.1111/jgh.13928.
    PubMed     Text format     Abstract available


    J Hepatol

  33. CHIANG DY, Villanueva A
    Progress towards molecular patient stratification of hepatocellular carcinoma: lost in translation?
    J Hepatol. 2017 Aug 21. pii: S0168-8278(17)32210.
    PubMed     Text format    

  34. PETTA S, Marchesini G
    Corrigendum to "Coffee and tea breaks for liver health" [J Hepatol 67 (2017) 221-223].
    J Hepatol. 2017 Aug 16. pii: S0168-8278(17)32186.
    PubMed     Text format    


    Lancet Infect Dis

  35. FORNS X, Lee SS, Valdes J, Lens S, et al
    Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.
    Lancet Infect Dis. 2017 Aug 14. pii: S1473-3099(17)30496.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  36. WU HQ, Cheng ML, Lai JM, Wu HH, et al
    Flux balance analysis predicts Warburg-like effects of mouse hepatocyte deficient in miR-122a.
    PLoS Comput Biol. 2017;13:e1005618.
    PubMed     Text format     Abstract available


    PLoS One

  37. LEE J, Yoon K, Ryu S, Chang Y, et al
    High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    PLoS One. 2017;12:e0172666.
    PubMed     Text format     Abstract available

  38. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    PubMed     Text format     Abstract available

  39. INZAUGARAT ME, De Matteo E, Baz P, Lucero D, et al
    New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans.
    PLoS One. 2017;12:e0172900.
    PubMed     Text format     Abstract available

  40. GUTIERREZ-DE-JUAN V, Lopez de Davalillo S, Fernandez-Ramos D, Barbier-Torres L, et al
    A morphological method for ammonia detection in liver.
    PLoS One. 2017;12:e0173914.
    PubMed     Text format     Abstract available

  41. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available

  42. WU PY, Cheng CY, Liu CE, Lee YC, et al
    Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
    PLoS One. 2017;12:e0171596.
    PubMed     Text format     Abstract available

  43. PRAJAPATI HJ, Kim HS
    Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
    PLoS One. 2017;12:e0170750.
    PubMed     Text format     Abstract available

  44. TAI CS, Lin YR, Teng TH, Lin PY, et al
    Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
    PLoS One. 2017;12:e0171269.
    PubMed     Text format     Abstract available

  45. VAN DEN BERG EH, Amini M, Schreuder TC, Dullaart RP, et al
    Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    PLoS One. 2017;12:e0171502.
    PubMed     Text format     Abstract available

  46. LACOSTE B, Raymond VA, Cassim S, Lapierre P, et al
    Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
    PLoS One. 2017;12:e0171215.
    PubMed     Text format     Abstract available

  47. KAJI K, Mizukoshi E, Yamashita T, Arai K, et al
    Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170291.
    PubMed     Text format     Abstract available

  48. CHENG SB, Liu HT, Chen SY, Lin PT, et al
    Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection.
    PLoS One. 2017;12:e0170016.
    PubMed     Text format     Abstract available

  49. LOWDON RF, Wang T
    Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
    PLoS One. 2017;12:e0174032.
    PubMed     Text format     Abstract available

  50. HOLMILA R, Sklias A, Muller DC, Degli Esposti D, et al
    Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
    PLoS One. 2017;12:e0174265.
    PubMed     Text format     Abstract available

  51. LE MH, Devaki P, Ha NB, Jun DW, et al
    Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    PLoS One. 2017;12:e0173499.
    PubMed     Text format     Abstract available

  52. MO HY, Liao YY, You XM, Cucchetti A, et al
    Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
    PLoS One. 2017;12:e0174222.
    PubMed     Text format     Abstract available

  53. MA S, Yang J, Song C, Ge Z, et al
    Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0173700.
    PubMed     Text format     Abstract available

  54. TROUVE P, Genin E, Ferec C
    In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.
    PLoS One. 2017;12:e0173822.
    PubMed     Text format     Abstract available

  55. ABO-HADED HM, Elkablawy MA, Al-Johani Z, Al-Ahmadi O, et al
    Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity.
    PLoS One. 2017;12:e0174295.
    PubMed     Text format     Abstract available

  56. XIE Z, Wang J, Liu M, Chen D, et al
    CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
    PLoS One. 2017;12:e0173252.
    PubMed     Text format     Abstract available

  57. BECKER S, Kinny-Koster B, Bartels M, Scholz M, et al
    Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    PLoS One. 2017;12:e0174424.
    PubMed     Text format     Abstract available

  58. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    PubMed     Text format     Abstract available

  59. LI C, Ni J, Liu YX, Wang H, et al
    Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes.
    PLoS One. 2017;12:e0168049.
    PubMed     Text format     Abstract available


    Transplant Proc

  60. KORDA D, Deak PA, Kiss G, Gerlei Z, et al
    Management of Portal Hypertension After Liver Transplantation.
    Transplant Proc. 2017;49:1530-1534.
    PubMed     Text format     Abstract available

  61. LUO Y, Zhao D, Zhang M, Zhou T, et al
    Hepatic Artery Reconstruction Using 3-in-1 Segmental Resection in Pediatric Living Donor Liver Transplantation: A Case Report and Literature Review.
    Transplant Proc. 2017;49:1619-1623.
    PubMed     Text format     Abstract available

  62. PRUSINSKAS B, Kathemann S, Pilic D, Hegen B, et al
    Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.
    Transplant Proc. 2017;49:1628-1633.
    PubMed     Text format     Abstract available

  63. ALIYEV V, Yasuchika K, Hammad A, Badawy A, et al
    Coexistent End-stage Nonalcoholic Steatohepatitis and Colon Cancer: Should We Do Liver Transplantation?
    Transplant Proc. 2017;49:1649-1651.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: